Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003

@article{Lee2006ImpactsOC,
  title={Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003},
  author={Dr Yue-Chune Lee and Ming-Chin Yang and Yu-Tung Huang and Chien-Hsiang Liu and Sun-Bing Chen},
  journal={PharmacoEconomics},
  year={2006},
  volume={24},
  pages={891-902}
}
Introduction: Pharmaceutical expenditure (PE) of the National Health Insurance (NHI) programme in Taiwan grew from 62.2 billion Taiwan new dollars ($NT) in 1996 to $NT94.5 billion in 2003.The government has been introducing many strategies to control PE since the inception of NHI including price adjustment based on the prices of international products or existing products (inter-brands comparison), or market price and volume survey; delegation of financial responsibility to regional bureaux; co… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Global budgets and provider incentives: hospitals' drug expenditures in Taiwan.

Advances in health economics and health services research • 2010
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Pharmaceutical benefit scheme and Correspondence and offprints: Dr Yue-Chune Lee, Institute cost containment in Taiwan’s National Health Insurance. of Health and Welfare Policy, National Yang-Ming

WF Huang, HC Chiang
Univer J Pharm Finance Econ Policy • 2003
View 2 Excerpts

Moral hazard and consumer incentives in health care

TG McGuire
Since the NHI programme was launched , Taiwan Handbook of health economics • 2000

Comparison of Taiwan ’ s NHI drug price and international drug price [ in Chinese ] . Chin JY . - C . Lee and M . - C . Yang were responsible for the study Public Health

WF Huang, KL Lo, LW Chen
1998

Similar Papers

Loading similar papers…